Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Truway Health Inner Ear Regeneration & Hearing Restoration Trial
NCT07472023Phase 1Enrolling by invitation
- Start
- Mar 2026
- Primary completion
- Mar 2097
- Countries
- 1
01
Overview
Phase 1 trial in sensorineural hearing loss (SNHL), tinnitus and inner ear injury (4 arms). Primary endpoint: Pure-Tone Audiometry Hearing Threshold at 6 months. Started Mar 2026; status: enrolling by invitation.
02
Conditions
sensorineural hearing loss (SNHL)tinnitusinner ear injury
Beyond the preview
Go deeper on NCT07472023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07472023.